REPL- Replimune Group, Inc.

Name: Replimune Group, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Replimune Group, Inc. (REPL) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. REPL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Astley-Sparke Philip	1.43M	$5.68M	-
CEO	Patel Sushil	533.6K	$2.12M	-
Other	Xynos Konstantinos	199.7K	$792.7K	-
CFO	Hill Emily Luisa	194.4K	$771.6K	-
Other	Schwendenman Andrew	78.3K	$310.8K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 18, 2021	Omega Fund Iv, L.P.81	Director, 10% Owner	Sell	2,594	$33.50	$86,899.00	-	-47.5%	-43.1%
Nov 15, 2021	Omega Fund Iv, L.P.81	Director, 10% Owner	Sell	24,017	$33.66	$808,412.22	-0.2%	-48.7%	-40.4%
Nov 11, 2021	Omega Fund Iv, L.P.81	Director, 10% Owner	Sell	18,290	$33.61	$614,725.69	-0.2%	-44.1%	-37.7%
Nov 9, 2021	Omega Fund Iv, L.P.81	Director, 10% Owner	Sell	11,354	$33.66	$382,207.02	-0.1%	-43.5%	-46.2%
Nov 5, 2021	Omega Fund Iv, L.P.81	Director, 10% Owner	Sell	31,015	$33.57	$1,041,020.50	-0.3%	-45.4%	-44.6%
Oct 18, 2021	Love Colin72	Chief Operating Officer	Sell	30,000	$30.06	$901,890.97	-1.3%	-25.6%	-36.8%
Sep 23, 2021	Omega Fund Iv, L.P.81	Director, 10% Owner	Sell	12,171	$33.58	$408,702.18	-0.2%	-17.0%	-52.8%
Sep 17, 2021	Omega Fund Iv, L.P.81	Director, 10% Owner	Sell	100,000	$32.99	$3,299,008.74	-0.7%	-21.9%	-49.4%
Sep 15, 2021	Love Colin72	Chief Operating Officer	Sell	30,000	$31.23	$936,900.00	-3.7%	-12.2%	-44.4%
Aug 16, 2021	Love Colin72	Chief Operating Officer	Sell	30,000	$29.93	$898,029.00	-1.8%	+10.9%	-30.8%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC